FDCDDQ
EPRX

Federation des caisses Desjardins du Quebec’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49K Hold
9,091
– – ﹤0.01% 1867
2025
Q4 		$67.9K Hold
9,091
– – ﹤0.01% 1744
2025
Q3 		$51.6K Buy
+9,091
New +$49.5K ﹤0.01% 1800
2024
Q3 		– Sell
-545
Closed -$1.39K – 2723
2024
Q2 		$1.39K Buy
+545
New +$1.52K ﹤0.01% 2149

Other funds holding EPRX

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's EPRX Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Eupraxia Pharmaceuticals (EPRX) position steady in Q1 2026 at 9,091 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

Federation des caisses Desjardins du Quebec first reported a position in EPRX in Q2 2024 and has held it in 4 quarters since. The position peaked at $67.9K in Q4 2025. 54 funds tracked by Wall St. Rank hold EPRX as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 9,091 shares of Eupraxia Pharmaceuticals worth $49K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Eupraxia Pharmaceuticals share count unchanged in Q1 2026.
  • Eupraxia Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1867 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Eupraxia Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • Federation des caisses Desjardins du Quebec's Eupraxia Pharmaceuticals position peaked at $67.9K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.